Table 1.

Characteristics of Covid-19 patients receiving or not bronchodilator inhalers.

Characteristic	Total (N = 327)	%	Bronchodilator inhalers (N = 124)	%
Age
<40 years	28/327	8.5%	6/28	4.8%
40–59 years	87/327	26.5%	27/87	21.6%
60–79 years	157/327	47.9%	71/157	56.8%
≥80 years	56/327	17.1%	21/56	16.8%
Comorbidity	229/327	69.8%	92/125	73.6%
Hypertension	90/229	39.3%	59/92	54.3%
Obesity	25/229	10.9%	11/92	11.9%
Cancer	32/229	14%	13/92	14.1%
Cardiovascular	63/229	27.5%	26/92	28.2%
Diabetes	61/229	26.6%	25/92	27.2%
Other	92/229	40.2%	25/92	27.2%
Respiratory illness at baseline	69/327	21.1%	43/124	21.8%
COPD	42/69	60.9%	27/43	62.8%
Asthma	13/69	18.8%	12/43	2.8%
OSAS	13/69	18.8%	11/43	2.5%
Other	10/69	14.5%	10/43	2.6%

COPD=Chronic obstructive pulmonary disease. OSAS=Obstructive sleep apnea syndrome.